About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 131 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 131 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 131 trials

CompletedA Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic MedicationsThis phase 2, double blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese adults with…NCT03818256·Bentonville, Arkansas and 26 others RecruitingBilateral Prefrontal and Insular TMS for Depression in SchizophreniaThe purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia.NCT07060066·Houston, Texas CompletedA Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective DisorderThis Phase IV, randomized, parallel-group study is designed to evaluate the cataractogenic potential of quetiapine fumarate (SEROQUEL) compared with that of a putative…NCT00206102·Little Rock, Arkansas and 62 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedOlanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaThis is a research study comparing the safety and efficacy of two active study medicationsNCT00034801·Tuscaloosa, Alabama and 29 others

CompletedOpen-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderThis is a long-term, open-label clinical study designed to enable longer-term treatment of patients completing other clinical studies with intramuscular olanzapine depot.NCT00088465·Orange, California and 91 others

CompletedAn Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with…NCT05304767·Phoenix, Arizona and 93 others

CompletedEfficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With SchizophreniaNegative symptoms and cognitive dysfunction in schizophrenia (CDS) are core features of schizophrenia.NCT01488929·Garden Grove, California and 63 others

CompletedCognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)The investigators propose a cluster randomized effectiveness trial comparing Cognitive Adaptation Training (CAT; a psychosocial treatment using environmental supports such as…NCT03829280·Dayville, Connecticut and 7 others

CompletedA Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaThis is a safety and efficacy study evaluating a experimental treatment for cognitive deficits in adults with schizophrenia.NCT01655680·Anaheim, California and 60 others

CompletedEfficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaThis is an efficacy and safety study evaluating an experimental treatment for cognitive deficits in adults with schizophrenia.NCT01077700·Anaheim, California and 23 others

CompletedComparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase SchizophrenicsThe goal of this project is to show that the best possible option for preventing relapses in patients suffering from first episode (\<1 year of anti-psychotic medication) or early…NCT02360319·Tucson, Arizona and 38 others

CompletedAripiprazole Open-Label, Safety and Tolerability StudyThe purpose of this study is to test the long-term safety and tolerability of aripiprazole in adolescent patients with schizophrenia, and child and adolescent patients with…NCT00102518·Birmingham, Alabama and 49 others

RecruitingA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis…NCT06585787·Chandler, Arizona and 295 others

RecruitingTranscranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum DisordersThe purpose of this study is to determine if repetitive transcranial magnetic stimulation (rTMS) applied to angular gyrus (AG) will improve negative symptoms and/or other…NCT07290738·Houston, Texas

CompletedA Multi-Site Study of Strategies for Implementing Schizophrenia GuidelinesSchizophrenia, a chronic psychiatric disorder, is the second most frequent VA discharge diagnosis.NCT00013000·Washington D.C., District of Columbia and 5 others

CompletedEfficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderThe purposes of this study are to assess the efficacy, safety, and side effects among doses approved by the Food and Drug Administration and higher (not FDA approved) doses of…NCT00100776·Anaheim, California and 32 others

CompletedA Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current…NCT05145413·Phoenix, Arizona and 165 others

CompletedLong Term Study of RBP 7000 in the Treatment of Subjects With SchizophreniaThis is a Phase 3, open label study administering RBP-7000 in the treatment of patients with schizophrenia.NCT02203838·Little Rock, Arkansas and 47 others

RecruitingEnhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from H coil combined with cognitive training for…NCT06961916·Houston, Texas

CompletedEfficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaThe objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.NCT00654706·Garden Grove, California and 25 others

PreviousPage 3 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia